HCP life science innovation ApS: Financial statements 2026
CVR: 40003665
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
HCP life science innovation ApS (CVR 40003665) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 9,955 and a net result of DKK 34,931 compared with DKK -123,484 the year before. Equity in the 2026 report amounted to DKK 150,057. The solvency ratio was 8.2%.
- Gross Profit
- DKK 9,955
- Profit/Loss
- DKK 34,931
- Equity
- DKK 150,057
- Total Assets
- DKK 1,840,413
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 10K | 35K | 150K | 0 |
| 2025 | - | -124K | -123K | 115K | 0 |
| 2024 | - | -30K | -23K | 239K | - |
| 2023 | - | -514K | -206K | 262K | - |
| 2022 | - | -471K | -470K | 118K | - |
Official annual report
Find more companies like HCP life science innovation ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout HCP life science innovation ApS
HCP life science innovation ApS is a Danish company of the type Anpartsselskab based in Brande, founded in 2018. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Hans-Christoph Paul. The company is owned by HCP HOLDING ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 9,955 and a net result of DKK 34,931 compared with DKK -123,484 the year before. Equity in the 2026 report amounted to DKK 150,057.
